Concepedia

Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: A placebo-controlled trial

Jagdish Hiremath, S Thanikachalam, Keyur Parikh, Somasundaram Shanmugasundaram, Sudhakar Banġera, Leland Shapiro, Gregory B. Pott, Cindy L. Vnencak‐Jones, Carl Arneson, Michael S. Wade,

The Journal of Heart and Lung Transplantation · 2009 · 198 citations · 40 references

DOIFull text

Open access

Concepts

References

40

A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

Robyn J. Barst, Lewis J. Rubin, Walker Long et al. · New England Journal of Medicine · 1996 · 2.7K citations · Full text

, , +9

Inhaled Iloprost for Severe Pulmonary Hypertension

Horst Olschewski, Gérald Simonneau, Nazzareno Galiè et al. · New England Journal of Medicine · 2002 · 1.8K citations · Full text

, , +12

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

Richard N. Channick, G Simonneau, Olivier Sitbon et al. · The Lancet · 2001 · 1.5K citations

, , +13

Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial

Gérald Simonneau, Robyn J. Barst, Nazzareno Galiè et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 1.4K citations

, , +11

The Measurement of Dyspnea

Donald A. Mahler, David H. Weinberg, Carolyn K. Wells et al. · CHEST Journal · 1984 · 1.3K citations

, , +10